Last reviewed · How we verify
NCT03155074: HILT
High-Intensity Training Following Lung Transplantation
NA trial testing High-intensity training in Lung Transplant in 54 participants. Completed in 31 January 2019.
31 January 2019
Quick facts
| Lead sponsor | Oslo University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 22 August 2017 |
| Primary completion | 31 January 2019 |
| Estimated completion | 31 January 2019 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- High-intensity training
Conditions studied
- Lung Transplant — all drugs for Lung Transplant →
- Exercise Training — all drugs for Exercise Training →
Sponsor
Oslo University Hospital
Who can join
18 and older, any sex, with Lung Transplant or Exercise Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The HILT study is a prospective, single-blinded, randomized controlled trial comparing a high-intensity exercise training intervention with usual care among adult lung transplant recipients. Patients randomized to the training intervention arm will undergo individually tailored high-intensity exercise training (80-95% of maximum heart rate) three hours per week for 20 weeks. Training will be conducted at local fitness centers on a one-on-one basis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Exercise training for adult lung transplant recipients.
Gutierrez-Arias R, Martinez-Zapata MJ, Gaete-Mahn MC, Osorio D, et al · · 2021 · cited 13× · PMID 34282853 · DOI 10.1002/14651858.cd012307.pub2
Verify or expand the search:
- PubMed search for NCT03155074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High-intensity training
Trials testing the same drug.
- NCT03765385 — The Umeå High-Intensity Training Study · NA · completed
- NCT03329586 — High-intensity Training Safely Improves Exercise Capacity in Heart, Lung, Kidney, and Liver Transplant Recipients: a Com · NA · completed
Other recruiting trials for Lung Transplant
Currently open trials in the same condition.
- NCT07035743 — Bronchial Response to Exercise After Double Lung Transplantation · recruiting
- NCT06476132 — Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients · Phase 2 · recruiting
- NCT06033196 — Tocilizumab in Lung Transplantation · Phase 2 · recruiting
- NCT05924113 — A Study of Latin Dance for Post- Lung Transplant · NA · recruiting
- NCT05898776 — 10°C vs 4°C Lung Preservation RCT · NA · active not recruiting
Other Oslo University Hospital trials
Trials by the same sponsor.
- NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
- NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
- NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
- NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
- NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03155074 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
- Last refreshed: 28 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03155074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing